ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Help
Search
HC3.B Immunization: Percentage of adolescents ages 13–17 years vaccinated for selected diseases by poverty statusa and race and Hispanic origin,b 2006–2019

excel icon HC3B Excel Table
excel icon HC3B Standard Error Excel Table

  Total Below 100% poverty 100% poverty and above
Characteristic 2006c 2007c 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2006c 2007c 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2006c 2007c 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total
MMR (2 doses or more)d 86.9 88.9 89.3 89.1 90.5 91.1 91.4 91.8 90.7 90.7 90.9 92.1 91.9 91.9 87.1 87.8 87.8 90.3 89.7 91.7 90.5 89.5 90.5 90.6 91.6 93.4 89.6 89.3 91.1 91.4 92.0 91.8 90.8 90.9 91.1 92.4 92.2 91.7
HepB (3 doses or more)e 81.3 87.6 87.9 89.9 91.6 92.3 92.8 93.2 91.4 91.1 91.4 91.9 92.1 91.6 86.7 88.3 89.0 91.4 91.3 93.2 90.3 90.3 90.2 89.9 91.3 91.9 88.0 90.3 92.4 92.6 93.3 93.1 91.9 91.1 91.9 92.5 92.6 92.3
Var (1 dose or more)f 65.5 75.7 81.9 87.0 90.5 92.3 94.7 94.9 95.2 94.9 95.0 95.5 94.9 95.2 77.0 82.9 86.7 91.1 92.5 94.7 95.0 94.8 95.2 94.4 94.0 95.2 82.9 87.6 91.2 92.6 95.3 95.2 95.2 94.7 95.1 95.7 95.1 95.3
Var (2 doses or more)g 34.1 48.6 58.1 68.3 74.9 78.5 81.0 83.1 85.6 88.6 89.6 90.6 35.8 46.2 53.8 67.2 72.0 77.3 82.7 85.4 85.0 88.2 89.2 92.6 33.9 48.7 58.9 68.4 75.8 79.0 80.8 82.2 85.9 88.6 89.9 90.3
Td or Tdap (1 dose or more)h 60.1 72.3 72.2 76.2 81.2 85.3 88.5 89.1 89.8 89.6 90.6 90.7 91.2 91.9 70.9 71.8 76.8 81.5 88.1 88.6 88.7 89.5 90.4 90.4 90.6 91.3 72.7 77.0 82.2 86.5 88.6 89.2 90.4 89.6 90.7 90.7 91.2 92.0
Tdap (1 dose or more)i 10.8 30.4 40.8 55.6 68.7 78.2 84.6 86.0 87.6 86.4 88.0 88.7 88.9 90.2 38.6 52.8 64.7 74.0 83.6 85.2 85.8 85.0 86.7 88.2 87.5 88.8 41.2 56.1 69.5 79.5 85.1 86.4 88.4 87.0 88.4 88.8 89.2 90.5
MenACWY (1 dose or more)j 11.7 32.4 41.8 53.6 62.7 70.5 74.0 77.8 79.3 81.3 82.2 85.1 86.6 88.9 40.8 52.5 62.0 69.0 73.2 78.4 79.0 82.6 82.9 85.7 86.2 90.2 42.0 53.8 62.9 70.7 74.1 77.5 79.5 80.5 82.0 84.8 86.6 88.6
HPV (1 dose or more)—females onlyk 25.1 37.2 44.3 48.7 53.0 53.8 57.3 60.0 62.9 65.1 68.6 69.9 73.2 46.4 51.9 51.8 62.1 64.9 66.8 67.2 70.0 74.8 75.7 78.7 75.9 35.8 42.5 47.7 50.1 50.4 54.6 57.7 60.4 62.0 66.5 67.4 72.6
HPV (up-to-date)—females onlyl 17.9 26.7 32.0 34.8 33.4 37.6 39.7 41.9 43.0 53.1 53.7 56.8 14.9 25.5 28.2 39.0 36.2 41.5 44.7 44.4 48.0 58.1 59.4 59.4 18.6 26.8 32.9 33.4 32.5 36.4 37.9 41.3 42.4 51.8 52.2 55.7
HPV (1 dose or more)—males onlym 1.4 8.3 20.8 34.6 41.7 50.0 56.0 62.6 66.3 69.8 14.1 29.9 46.7 51.6 61.1 65.8 71.1 73.8 75.1 6.7 17.3 30.8 39.5 46.0 52.8 59.1 64.3 68.2
HPV (up-to-date)—males onlyn 1.3 6.8 13.9 21.6 28.1 31.5 44.3 48.7 51.8 2.5 10.7 16.7 27.2 31.0 36.0 49.5 54.9 57.2 1.1 5.5 13.0 20.2 27.4 30.3 41.7 47.1 51.2
HPV (1 dose or more)o 30.1 36.9 44.9 50.6 56.1 60.4 65.5 68.1 71.5 38.0 47.5 55.8 59.5 65.3 70.2 73.3 76.2 75.5 27.7 33.3 41.7 48.3 53.1 57.3 62.8 65.8 70.3
HPV (up-to-date)p 17.6 19.8 24.8 30.4 34.9 43.4 48.6 51.1 54.2 20.7 23.5 28.2 36.1 37.4 50.1 53.7 57.1 58.3 16.7 18.5 23.9 28.7 34.2 41.7 46.7 49.6 53.4
White, non-Hispanic
MMR (2 doses or more)d 89.9 90.2 91.6 91.4 92.4 92.8 91.0 91.7 91.8 92.6 92.8 93.1 89.2 86.7 90.4 88.5 89.9 93.3 87.7 89.4 91.6 93.7 92.1 93.3 89.7 90.4 91.7 91.9 92.8 92.7 91.4 91.9 92.0 92.5 92.9 93.1
HepB (3 doses or more)e 88.1 90.2 92.7 92.8 93.7 93.8 92.2 92.5 92.4 92.4 93.2 93.8 88.4 87.4 90.8 90.7 91.7 94.6 89.7 90.8 90.3 92.3 92.9 93.4 87.9 90.5 92.8 93.1 94.0 93.7 92.5 92.5 92.8 92.6 93.3 94.1
Var (1 dose or more)f 82.8 88.5 91.2 92.9 95.3 95.3 95.1 95.4 95.5 96.2 95.8 96.1 74.4 79.3 85.6 91.2 91.9 95.6 93.2 95.0 95.4 96.9 95.5 94.4 82.9 88.9 91.7 93.2 95.7 95.5 95.4 95.3 95.5 96.2 95.9 96.3
Var (2 doses or more)g 31.6 48.8 59.2 67.3 74.0 77.7 80.0 82.8 86.1 89.1 90.8 92.0 34.2 42.9 60.8 61.8 73.1 75.1 82.3 84.1 90.6 90.8 91.0 49.1 68.1 75.6 78.5 80.5 82.8 86.5 88.8 90.9 92.2
Td or Tdap (1 dose or more)h 71.6 76.5 80.9 85.1 87.9 88.8 90.3 88.9 91.5 91.4 91.8 92.3 64.5 68.6 70.2 77.5 84.9 88.7 85.6 86.4 88.5 92.3 92.0 92.7 72.3 77.1 82.1 86.2 88.3 89.0 91.0 89.4 91.8 91.4 91.6 92.0
Tdap (1 dose or more)i 41.7 55.8 68.6 78.6 84.4 85.9 88.6 86.6 89.3 89.7 89.7 91.1 32.8 49.5 57.5 70.7 80.7 84.9 83.9 83.3 85.7 90.7 89.1 91.9 42.5 56.1 69.9 79.6 85.0 86.3 89.3 87.3 89.6 89.8 89.8 90.9
MenACWY (1 dose or more)j 39.7 53.1 61.2 68.4 71.3 75.6 78.2 79.5 81.2 84.6 86.0 88.4 32.8 47.1 50.3 58.5 63.2 72.3 72.9 75.8 79.2 86.0 84.9 91.6 40.3 53.3 62.5 69.7 72.5 76.2 79.1 80.0 81.6 84.4 85.9 87.9
HPV (1 dose or more)—females onlyk 35.0 43.9 45.8 47.5 51.1 53.1 56.1 59.2 60.0 63.6 66.1 70.5 33.6 52.5 39.4 53.6 56.2 53.9 56.7 63.2 67.2 68.9 75.5 69.5 35.7 43.0 46.6 46.7 50.6 53.4 56.6 59.3 59.1 63.5 64.9 70.9
HPV (up-to-date)—females onlyl 19.5 29.1 32.4 33.0 33.7 34.9 37.5 39.6 40.4 49.7 50.7 53.9 25.7 32.5 30.8 34.1 37.0 36.4 44.2 52.6 54.9 51.3 32.8 33.0 34.3 35.0 38.1 40.3 40.1 49.7 50.0 53.9
HPV (1 dose or more)—males onlym 5.6 15.2 26.7 36.4 43.8 49.7 56.7 61.1 66.3 8.9 18.1 30.9 39.4 44.8 57.3 65.8 66.1 71.8 5.3 14.5 26.1 36.5 43.4 48.5 55.3 60.4 65.8
HPV (up-to-date)—males onlyn 0.8 4.6 11.1 18.8 25.2 29.6 40.2 45.0 49.4 5.2 11.4 20.5 19.8 29.5 48.5 51.3 57.2 0.7 4.4 11.2 18.8 26.2 29.9 38.6 44.7 48.7
HPV (1 dose or more)o 25.7 32.5 39.2 45.8 51.4 54.7 60.0 63.5 68.3 30.3 36.2 42.3 47.5 53.8 62.2 67.3 70.6 70.7 25.0 32.0 39.0 46.0 51.2 53.6 59.2 62.6 68.3
HPV (up-to-date)p 16.2 18.6 22.4 27.7 32.3 39.6 44.7 47.8 51.6 16.2 17.4 22.9 28.2 27.9 42.7 50.5 53.1 54.4 16.1 18.9 22.4 27.9 33.1 39.4 44.0 47.3 51.2
Black, non-Hispanic
MMR (2 doses or more)d 89.1 86.3 90.8 90.6 91.4 91.1 91.1 91.9 91.6 91.8 93.1 92.5 89.1 84.4 92.1 90.7 91.0 90.6 89.8 91.6 92.0 89.4 93.0 92.7 88.6 86.9 90.2 90.8 91.5 91.5 91.7 91.8 91.9 92.7 92.9 92.7
HepB (3 doses or more)e 86.0 88.9 90.9 91.7 92.5 93.2 91.4 92.5 92.3 91.6 93.1 91.2 86.9 86.6 90.0 91.3 91.6 92.5 89.2 92.5 91.7 89.1 92.3 91.5 85.8 89.8 91.3 92.3 93.1 94.0 92.8 92.3 93.2 92.6 94.0 91.6
Var (1 dose or more)f 74.0 82.4 89.2 91.3 93.3 94.3 95.3 95.3 96.1 94.5 94.2 95.4 72.7 79.8 87.0 91.1 93.1 92.8 96.4 95.1 96.4 92.8 93.4 95.9 74.8 82.8 89.5 91.2 93.3 95.4 95.2 95.3 95.8 95.2 94.4 95.1
Var (2 doses or more)g 35.0 43.9 55.3 65.3 75.2 77.9 84.6 84.9 87.0 88.9 89.4 92.2 44.4 60.3 64.7 71.7 77.6 87.7 85.6 87.6 86.8 89.7 94.2 44.2 51.8 65.3 76.5 77.8 83.3 84.3 87.2 89.6 89.1 91.8
Td or Tdap (1 dose or more)h 71.4 72.5 80.5 83.1 87.7 87.4 89.6 91.4 92.8 91.9 90.7 92.3 68.9 69.5 80.1 79.1 87.5 84.8 88.8 89.3 94.2 91.2 88.5 93.5 71.9 74.8 80.1 85.4 87.6 88.9 89.9 92.2 92.2 92.3 91.2 92.2
Tdap (1 dose or more)i 36.0 52.7 66.9 75.7 83.7 84.1 87.6 86.0 89.6 89.7 88.4 89.1 39.0 47.7 68.1 72.1 84.1 82.5 86.7 84.2 90.1 89.0 86.4 88.5 33.4 55.6 66.0 77.7 84.0 84.7 88.0 86.4 89.2 90.0 88.6 89.7
MenACWY (1 dose or more)j 43.1 53.0 63.4 72.1 75.8 77.0 80.3 81.7 85.5 85.7 87.1 89.4 38.8 52.0 66.5 72.0 75.3 72.4 79.5 83.0 87.4 84.5 87.1 88.2 44.4 53.8 61.4 71.5 76.6 79.6 80.4 80.5 84.6 86.6 87.4 90.5
HPV (1 dose or more)—females onlyk 35.7 44.6 48.9 56.0 50.1 55.8 66.4 66.9 70.0 72.8 74.6 72.4 45.9 51.6 55.7 60.2 59.9 64.0 70.6 72.3 79.9 86.8 75.2 79.4 31.2 40.7 44.5 52.5 46.2 50.8 62.3 62.7 63.7 65.6 75.7 70.2
HPV (up-to-date)—females onlyl 14.9 23.1 30.2 31.7 29.0 34.2 39.0 40.8 43.3 55.6 58.4 53.2 31.6 36.6 33.8 39.0 41.1 43.4 51.5 66.2 59.6 62.5 28.6 28.0 26.4 31.6 36.0 39.2 37.0 50.0 59.6 49.4
HPV (1 dose or more)—males onlym 10.6 25.9 42.2 42.1 54.0 61.4 67.3 71.2 71.7 10.2 29.9 44.3 46.9 60.2 67.4 74.1 73.2 65.9 10.4 22.9 41.3 40.7 51.9 59.6 63.6 70.2 73.9
HPV (up-to-date)—males onlyn 5.4 15.7 20.4 26.0 30.1 44.9 48.5 55.3 15.1 18.6 27.3 31.8 47.3 46.2 47.9 6.2 16.0 22.4 26.0 30.1 44.3 49.3 58.2
HPV (1 dose or more)o 33.4 37.8 47.4 54.6 60.1 65.9 70.0 72.8 72.0 36.3 44.7 53.3 59.7 66.5 74.3 80.0 74.3 72.5 31.0 34.3 44.2 51.5 56.7 61.7 64.6 72.7 72.2
HPV (up-to-date)p 16.5 17.0 24.0 30.0 32.9 46.0 50.2 53.3 54.3 19.9 18.5 27.0 30.7 35.6 52.2 56.1 53.4 55.0 14.3 16.1 22.5 29.2 31.8 42.8 47.2 54.1 54.2
Hispanic
MMR (2 doses or more)d 87.5 87.6 86.2 90.6 89.1 90.2 90.5 88.1 88.9 91.0 89.9 89.0 83.9 90.6 83.5 91.7 87.7 91.2 92.1 88.9 88.8 88.9 91.5 93.7 90.4 85.4 88.1 89.4 90.2 89.5 89.9 87.1 88.9 91.8 89.3 86.6
HepB (3 doses or more)e 89.8 90.0 88.9 91.7 91.1 92.8 90.5 87.4 89.2 91.8 89.1 87.3 86.2 90.3 87.8 93.0 91.1 93.0 90.9 88.6 88.5 88.9 89.6 91.2 92.1 89.8 91.0 90.7 91.0 92.2 90.9 85.9 89.6 93.3 89.2 87.5
Var (1 dose or more)f 84.5 85.5 90.6 91.0 94.1 94.5 95.5 93.1 93.0 94.8 93.4 93.5 80.0 84.6 88.1 92.5 92.1 95.3 95.2 94.3 93.8 93.5 94.5 95.1 88.9 85.6 92.1 89.6 95.7 94.0 95.4 91.6 93.8 95.1 92.8 92.8
Var (2 doses or more)g 38.5 49.7 56.2 71.4 76.3 80.3 82.5 82.3 84.2 88.0 87.6 88.3 49.7 55.8 73.8 76.8 80.2 85.9 87.0 84.6 87.9 88.9 92.4 49.4 56.7 69.4 76.2 80.7 80.0 77.8 84.2 88.1 87.4 83.4
Td or Tdap (1 dose or more)h 74.1 76.7 82.4 86.7 89.6 90.5 90.4 89.8 88.4 88.5 90.8 90.5 74.8 74.2 78.9 85.0 89.3 90.1 91.1 91.7 89.6 88.9 91.0 89.1 75.7 77.4 85.0 88.3 90.0 90.3 90.5 88.1 88.4 87.4 90.4 91.5
Tdap (1 dose or more)i 41.9 55.6 69.6 78.4 85.4 87.1 86.7 85.3 85.4 86.4 87.7 88.5 40.4 55.8 67.4 76.1 84.1 86.6 86.4 86.6 85.6 86.2 87.3 86.5 44.0 54.8 70.6 80.6 86.8 87.2 87.2 84.3 85.8 85.3 88.1 89.7
MenACWY (1 dose or more)j 46.8 55.9 66.1 75.3 77.6 83.4 82.1 85.0 83.8 86.0 87.6 89.3 45.0 56.2 67.4 77.2 78.3 86.5 83.2 86.8 83.5 86.6 86.5 90.4 48.9 55.9 64.4 73.6 76.4 80.0 81.3 82.0 84.0 84.7 88.2 88.8
HPV (1 dose or more)—females onlyk 44.4 45.5 56.2 65.0 62.9 67.5 66.3 68.4 71.8 76.0 75.3 78.9 53.0 52.2 57.9 69.2 73.9 76.1 72.4 72.9 76.7 74.8 82.4 76.9 39.3 42.0 53.5 61.9 52.2 60.4 59.8 62.6 68.2 75.4 69.0 79.0
HPV (up-to-date)—females onlyl 14.7 23.4 29.5 41.6 35.5 44.8 46.9 46.2 45.9 58.1 57.2 62.8 27.1 44.9 40.9 47.2 51.2 48.9 48.3 57.3 61.4 62.4 32.9 39.5 30.3 42.2 41.2 44.4 48.8 58.7 53.4 62.1
HPV (1 dose or more)—males onlym 14.9 31.7 49.6 54.2 58.9 67.8 73.0 75.8 74.6 20.4 39.8 59.1 61.1 70.8 72.0 73.7 79.3 81.6 11.2 23.5 42.7 50.6 48.3 64.2 68.7 74.1 69.8
HPV (up-to-date)—males onlyn 2.7 12.9 20.3 27.8 35.0 37.2 54.6 56.0 53.3 3.2 19.1 22.3 33.7 39.4 43.9 54.8 60.4 62.5 7.6 18.6 24.1 31.0 31.8 51.6 52.8 52.3
HPV (1 dose or more)o 40.7 47.0 56.6 60.2 63.6 69.8 74.5 75.5 76.8 44.4 57.3 66.3 66.9 71.7 74.0 74.3 80.8 79.3 38.3 37.0 49.6 55.1 55.6 66.2 72.2 71.5 74.4
HPV (up-to-date)p 22.7 24.0 30.3 37.3 40.5 49.9 56.4 56.6 58.1 23.7 30.3 32.6 42.7 43.7 55.7 56.1 60.9 62.4 22.3 18.3 28.6 32.5 37.9 47.4 55.3 53.1 57.2
— Not available.
a Based on family income and household size using U.S. Census Bureau poverty thresholds for the year of data collection.
b The revised 1997 U.S. Office of Management and Budget standards for data on race and ethnicity were used. Persons could select one or more from the following racial groups: White, Black or African American, American Indian or Alaska Native, Asian, or Native Hawaiian or Other Pacific Islander. Persons of Hispanic origin may be of any race. Included in the total but not shown separately are American Indian or Alaska Native, Asian, Native Hawaiian or Other Pacific Islander, and "Two or more races" because of the small sample size. Data on race and Hispanic origin are collected separately but combined for reporting.
c Data collection for 2006 and 2007 was only performed during the fourth quarter of each year.
d Includes 2 doses (or more) of measles-mumps-rubella vaccine (MMR) received at any age.
e Includes 3 doses (or more) of hepatitis B vaccine (HepB) received at any age.
f Includes 1 dose (or more) of varicella vaccine (Var) received at any age and without a history of varicella disease.
g Includes 2 doses (or more) of Var received at any age and without a history of varicella disease.
h Includes 1 dose (or more) of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) since age 10.
i Includes 1 dose (or more) of Tdap since age 10.
j Includes 1 dose (or more) of meningococcal conjugate vaccine (MenACWY) and meningococcal-unknown type vaccine.
k Includes 1 dose (or more) of nine valent or quadrivalent or bivalent human papillomavirus (HPV) vaccine. Percentages reported among females only.
l Includes up-to-date for nine valent or quadrivalent or bivalent HPV vaccine. Percentages reported among females only. Up-to-date is 3 doses HPV vaccine or 2 doses HPV vaccine when first dose is received prior to age 15 years and there is at least 5 months minus 4 days between the first and second dose.
m Includes 1 dose (or more) of nine valent or quadrivalent or bivalent HPV vaccine. Percentages reported among males only.
n Includes up-to-date for nine valent or quadrivalent or bivalent HPV vaccine. Percentages reported among males only. Up-to-date is 3 doses HPV vaccine or 2 doses HPV vaccine when first dose is received prior to age 15 years and there is at least 5 months minus 4 days between the first and second dose.
o Includes 1 dose (or more) of nine valent or quadrivalent or bivalent HPV vaccine. Percentages reported among all adolescents.
p Includes up-to-date for nine valent or quadrivalent or bivalent HPV vaccine. Percentages reported among all adolescents. Up-to-date is 3 doses HPV vaccine or 2 doses HPV vaccine when first dose is received prior to age 15 years and there is at least 5 months minus 4 days between the first and second dose.
NOTE: Data include routinely recommended vaccines (Tdap, MenACWY, HPV vaccine) and early childhood vaccines (MMR, HepB, Var) for catch-up coverage estimates. A revised adequate provider data definition was implemented in 2014 NIS-Teen. See http://www.cdc.gov/vaccines/imz-managers/coverage/nis/teen/apd-report.html. Estimates prior to 2014 are not directly comparable with those from 2014 and beyond.
SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey—Teen.